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Abstract 
Background: To find out the spectrum of childhood 
malignancies  
Methods: In this descriptive study all  children under 
12 years, admitted at Fauji Foundation Hospital 
Rawalpindi,  with confirmed diagnosis of any malignancy 
by means of histological or cytological examinations were 
included. 
Results:  Out of  81 cases of malignancies  forty two 
(51.9%) were between 5-9 years of age, 20(24.7%) were 0-5 
years of age and 19(23.5%) were 9-12 years of age. The 
frequency of paediatric malignancies was found to be 
higher among boys (66.7%). Leukemia (54.3%) was the 
commonest followed by Lymphoma (23.5%) and Wilm’s 
tumor (8.6%).  
Conclusion: Peak age incidence for malignancies is 5-9 
years (51.5%). The most common malignancy in age group 
0-5 years is Wilm’s tumor (6.2%) while ALL is common in 
age groups 5-9 years and 9-12 years (30.9% and 9.9% 
respectively) . 
 Key Words:Paediatric malignancies;Leukemia;  
Lymphoma  
 
Introduction 
      Malignant neoplasms are uncommon in children. 
Childhood cancers respond to treatment rapidly and 
the survival has improved dramatically over the last 
two decades due to intensive combined modality 
management .1 Cancer is a common cause of mortality 
in many developed countries and in USA it is the 
second most common cause of mortality in children 
under 14 years of age. More than 10% of all deaths in 
children below 15 years of age are caused by 
malignant diseases in developed countries. In the 
developing world, childhood cancers are yet to be 
recognized as a major pediatric cause of death due to 
several other competing causes of death like diarrhea 
and respiratory illnesses. 2 
The pattern of prevalence of paediatric 
malignancies has similarities, but  there are 
considerable differences which highlights the 
importance of regional epidemiological studies. 
Leukemia is the most common childhood neoplasm in 
many countries followed by central nervous system 
tumors and lymphoma . Reports from other countries 
show diversities, e.g.: in Nigeria the most common 
childhood malignancy is lymphoma, while Leukemia 
is in the fourth position . Moreover, the pathological 
subtypes of different cancers vary from one region to 
another. 3-9  
      Paediatric cancers differ markedly from adult 
malignancies in both prognosis and distribution by 
histology and tumor site. Lymphohematopoietic 
cancers (i.e.,Acute lymphoblastic leukemia, 
lymphomas) account for approximately 40%, nervous 
system cancers for approximately 30% and embryonal 
tumours and sarcomas for approximately 10%, each 
among the broad categories of childhood cancers. 
During infancy embryonal tumors such as 
Neuroblastoma, Wilm’s tumor, Retinoblastoma, 
Rhabdomyosarcoma, Hepatoblastoma and 
Medulloblastoma are most common. 10-14 
 
Patients and Methods 
     All cases of Paediatric malignancies admitted in 
oncology ward of Paediatric Department, Fauji 
Foundation Hospital (FFH), Rawalpindi from 
November 2009 to March 2011, were included .FFH, 
RWP is a 600 bedded tertiary care hospital. Paediatric 
Department FFH has a 10 bedded Oncology ward. The 
clinical profile of childhood malignancies was studied 
focusing on the prevalence of malignancies according 
to age, sex, subtype, staging, type of protocol used, 
remission/relapse and outcome of the treatment. 
Patients were divided into 3 different age groups; 0-5 
yrs, 5-9 yrs and 9-12 yrs. Canadian chemotherapy 
protocols were used in the  patients.   
 
Results 
     There were eighty one (81) confirmed new cases of 
childhood malignancies admitted from Nov 2009 to 
Mar 2011. ALL was the commonest (Table 1).  Forty 
two (51.9%) cases were between 5-9 years of age. 
20(24.7%) belonged to 0-5 years of age and 19(23.5%) 
were 9-12 years old (Table 2 ).  Out of 81 patients, 68% 
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were male and 32% were female, with a male: female 
ratio of 2.1:1.  
      Among Lymphomas, there were 11 cases (57.9%) of 
Hodgkin’s lymphoma and 8 cases (42.1%) of Non- 
Hodgkin’s lymphoma. All cases of Hodgkin’s 
Lymphoma were of mixed cellularity type and among 
NHL, 5 (62.5%) cases were Burkitt’s lymphoma and 
3(37.5%) cases were of anaplastic large cell 
type.Among Hodgkin’s lymphoma 5 (45.5%) cases 
were of stage IIBX, 4(36.4%) cases were of stage IIB 
and 1(9.1%) case each of stage IIIBX and IIIB. Among 
NHL, out of 5 cases of Burkitt’s lymphoma 3(60%) had 
stage IIIB and 2(40%) had stage III. All 3 cases of 
anaplastic large cell type were of stage IIIB. Among 7 
cases of Wilm’s tumor, 5(71.4%) were of stage IV and 1 
(14.3%) case each of stage I and II.Among ALL, 84.2% 
patients of ALL-L1 went into remission. . Among 
AML, all patients of AML-M1 (2 cases) and 75% cases  
of AML-M2 went into remission. The only case of 
AML-M5 failed to achieve remission. Among NHL, all 
5 patients of Burkitt’s lymphoma and 3 patients of 
Anaplastic large cell type achieved remission. 
      Among ALL, 31.5% of ALL-L1, 42.8% of ALL-L2 
and all patients  of ALL-L3 had relapse. Among AML, 
all patients of AML-M1 and M5 had relapse, while 1 
patient of AML-M2 had relapse, and 3 patients of 
AML-M2 were lost to follow up. Among NHL, 2 out of 
5 (40%) patients of Burkitt’s Lymphoma had relapse, 
while 1 was lost to follow up.1 out of 3 (33.3%) 
patients of Anaplastic large cell type had  relapse. 
    All patients of Hodgkin’s lymphoma (11 cases) 
remained well. Of 5 patients of Burkitt’s lymphoma, 
3(60%) expired, one was lost to follow up and one is 
still receiving treatment. All 3 patients of anaplastic 
large cell type expired. Overall, out of 8 patients of 
NHL, 6(75%) expired, one was lost to follow up and 
one is receiving chemotherapy. Out  of  7     patients of  
 
Table 1: Distribution of Paediatric 
Malignancies 
Diagnosis No (%) 
Acute lymphoblastic lymphoma 37(45.7) 
Hodgkin lymphoma 11(13.6) 
Non Hodgkin Lymphoma 8(9.9) 
Acute Myeloid leukemia 7(8.6) 
Wilm’s tumor 7(8.6) 
Neuroblastoma 2(2.5) 
Retinoblastoma 2(2.5) 
Neuroectodermal tumors 2(2.5) 
Rhabdomyosarcoma 2(2.5) 
Ewing’s Sarcoma 2(2.5) 
Yolk sac Tumour 1(1.2) 
Table 2: Paediatric Malignancies-Age Profile 
Diagnosis  
  
    Age in years 
 
0-5 years 
No(%) 
5-9 years 
No(%) 
9-12 years 
No(%) 
Acute Lymphoblastic 
Leukaemia (37) 
4(10.8) 25(67.6) 8 (21.6) 
Acute Myeloid 
Leukaemia (7) 
2 (28.6) 1(14.3) 4(57.1) 
Hodgkins’s Lymphoma 
(11) 
2 (18.2) 6(54.5) 3(27.3) 
Non- Hodgkins’s 
Lymphoma  (8) 
2 (25.0) 5(62.5) 1(12.5) 
Wilm’s Tumour (7) 5 (71.4) 2(28.6)  
Neuroblastoma (2) 2 (100)   
Retinoblastoma (2)   2 (100) 
Neuroectodermal 
Tumour (2) 
 1(50.0) 1(50.0) 
Yolk Sac Tumour (2) 1 (100)   
Rhabdomyosarcoma(2) 1(50.0) 1(50.0)  
Ewing’s Sarcoma (2) 1(50.0) 1(50.0)  
  Total(81) 20(24.7) 42(51.9) 19(23.5) 
 
Wilm’s tumor, 5(71.4%) expired and 2(28.4%) 
remained well. Two patients each of Retinoblastoma 
and Rhabdomyosarcoma are receiving chemotherapy. 
Two patients each of Neuroectodermal, Ewing’s 
sarcoma and Neuroblastoma expired. The only patient 
of Yolk sac tumor is under treatment. 
 
Discussion 
     Childhood tumors form a highly specific group 
arising in the lymphoreticular tissue, CNS, connective 
tissue and viscera. Epithelial tumors are rare. The 
general pattern of pediatric tumors in present series 
seems to resemble the distribution of pediatric cancers 
reported in a study conducted at Mayo Hospital, 
Lahore and another study from Iran. 15,16 Age 
distribution of different cancers was variable. The 
frequency of Neuroblastoma (100%), Yolk sac tumor 
(100%) and Wilm’s tumor (71.4%), were strikingly 
more in children 0-5 years of age. The early onset of 
many paediatric tumors suggests a prenatal origin. 
ALL (67.6%), NHL (62.5%), and Hodgkin’s disease 
(54.5%) were more common in 5-9 years age group. 
These findings were similar to a study conducted at 
Aga Khan University Hospital, Karachi.17 Sex 
predilection is a salient feature of many childhood 
tumors and varies with site and type of tumors. 
Genetic difference in immune function may be 
responsible for the increased incidence of lymphoid 
tumors in males. The female preponderance was seen 
in NHL,Wilm’s tumor, Neuroectodermal tumor, 
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Retinoblastoma, Neuroblastoma, Rhabdomyosarcoma 
and Ewing’s sarcoma. 
 
Conclusion 
Further efforts are required to ensure adequate 
management modalities for children with 
malignancies . 
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